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Abstract In this article we look at the evolution of
robotic technology in operative urology and the signiWcant
early contribution of Mr John Wickham. We explore the
ergonomics of robotic technology and discuss Wnancial
issues from a British perspective. We share our clinical
experience, describe the authors’ robotic-assisted cystec-
tomy technique, and conclude by exploring the patients’
perception of this new treatment modality.
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Introduction
The use of robotic-assisted laparoscopic surgery through-
out the world has increased signiWcantly in recent years
and is now standard practice in many large centres. Brit-
ish urologists were among the Wrst to contribute to the
development of surgical robotics and embrace this new
technology. Currently, robotic-assisted radical prostatec-
tomy is the most commonly performed robotic procedure
worldwide [1], and it is now gaining popularity in the
United Kingdom.
History
Man’s fascination with machines that are able to perform
automated work is hundreds of years old, with the evidence
for this scattered in the literature of several diVerent cul-
tures. Leonardo da Vinci probably designed the Wrst robot,
an automated knight capable of performing basic move-
ments to entertain the guests of Leonardo’s patron [2]. It
was not until the last three decades of the twentieth century
that robotic technology was developed for medical applica-
tions. The earliest machines were supportive robots used
for transporting pharmaceuticals and medical equipment,
and rehabilitation robots which provided physiotherapy to
joints and assisted stroke patients with their daily tasks. In
the 1980s researchers explored the potential of robotics in
operative surgery. Several projects in the United States and
in Europe started, some independently and some as collabo-
rative eVorts.
One of the Wrst pioneers was John Wickham, a urolo-
gist from Guy’s Hospital. He developed the Wrst clinically
useful robot in urology, the PROBOT in 1989 [3]. In the
late 1980s Wickham worked on a TURP robotic frame in
a joint project between the Mechanical Engineering
Department at Imperial College, Guy’s Hospital and the
Institute of Urology in central London. The device
attempted to perform an automated robotic transurethral
resection of the prostate (TURP). The team felt that as the
prostate is a relatively Wxed organ and the procedure
requires repeated similar movements, TURP was ideal for
robotic control. The frame was constructed to support a
six-axis Unimate Puma robot combined with a Wickham
Endoscope liquidizer and aspirator. The liquidizer blade
rotated at 40,000 rpm and the system was used in initial
clinical trials following successful tests on prostate-
shaped potatoes. These showed the PROBOT-assisted
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provided good haemostasis when used clinically. One
important concept in the design was that the tool could cut
or vaporize only within a physically restricted volume,
making the device intrinsically safe. Although never
mass-produced, this was the Wrst truly automated robotic
device in clinical use, as opposed to the subsequent mas-
ter–slave devices which technically perform robotic-
assisted surgery.
The master–slave systems (initially the telepresence
system) were developed as a collaborative eVort between
the National Aeronautics and Space Administration
(NASA) which had expertise in virtual reality and The
Stanford Research Institute (SRI) headed by Philip Green
in the 1980s [4]. Several years passed before the next
generation of robotic devices became available. Com-
puter Motion (Berkeley, CA, USA) introduced the Auto-
mated Endoscopic System for Optimal Positioning
(AESOP) in the mid-1990s. This system uses voice (or
pedal) control to direct the movements of a robotic arm,
which usually holds a laparoscopic camera. Another
robotic manipulator is the EndoAssist (Armstrong
Healthcare, High Wycombe, UK), a free-standing laparo-
scopic camera manipulator controlled by infrared signals
from a headset worn by the surgeon. It was also intro-
duced in the 1990s and although it is considerably less
expensive than the AESOP it takes up more space within
the operating room.
Computer Motion introduced its ZEUS Robotic Surgi-
cal System within a year of the introduction of da Vinci
by Intuitive Surgical (Sunnyvale, CA, USA). Both were
the Wrst commercially available master–slave robotic sur-
gical systems and both had a remote station that could
control laparoscopic instruments at the patient side. The
ZEUS system had AESOP incorporated in its design to
control the camera. Originally it only had 2-D imaging,
but it was later updated to 3-D vision using polarizing
glasses. Its robotic arms were attached independently to
the operating table. Tremor elimination and motion scal-
ing were possible. The combination of ZEUS with a tele-
communication system allowed Prof Marescaux in New
York to perform a laparoscopic cholecystectomy on a
patient in Strasbourg, France. This was the Wrst operation
to be performed on a human over a long distance and was
called the Lindbergh procedure [5]. In a comparative
study on animals, Sung and Gill noted that ZEUS pro-
vided Wve degrees of freedom (DOF) at the operative site,
and the learning curve and operations were longer than
those for the da Vinci system; however, this study was
done before the introduction of Microwrist to ZEUS sys-
tems [6]. After years of legal disputes Intuitive Surgical
acquired Computer Motion in 2003 and subsequently the
ZEUS system was phased out.
Basic science
The technology
The da Vinci is the most advanced master–slave system in
current clinical use with the introduction of the updated da
Vinci S in 2006. The system has been described in detail in
a previous publication of this journal and elsewhere [7, 8].
Its 3-D vision, enhanced magniWcation, motion scaling and
more importantly the EndoWrist technology make the
daVinci an easy-to-use, surgeon-friendly tool. Another
potential direction for the master–slave system is true tele-
robotic surgery, which has many applications in military
environments, space exploration and surgery in remote
areas where the skill of the surgeon can be utilised without
him or her being physically present at the patient side. The
Wrst telerobotic procedure was a prostate biopsy performed
by an Italian group in 1995 [9]. The Lindbergh operation
has already been mentioned above. Recently, Challacombe
et al. [10] found that robotic kidney needle access is slower
and more accurate compared to human in a randomised
controlled trial of telerobotic surgery between London and
Baltimore. Another application is robotic telementoring
[11], which enables an experienced surgeon to direct and
mentor another surgeon remotely.
Ergonomics
Laparoscopy remains at the forefront of urological mini-
mally-invasive surgery; however, many procedures are
technically demanding, with a considerable learning curve.
Manipulation of long laparoscopic instruments causes a
number of ergonomic problems. There is a fulcrum eVect at
the point of trocar insertion through the abdominal wall,
where a hand movement to the right produces a counterin-
tuitive movement to the left at the tip of the instrument
within the operative Weld. Instruments are long and move in
a cone-shaped way with the tip of the cone at the trocar
insertion point on the abdominal wall. Arc-like movements
of the upper extremity are necessary to produce small
movements of the end eVector, leading to reports of arm
and neck pain among laparoscopic surgeons [12]. The pis-
tol-type handle forces the hand into extreme positions of
Xexion and ulnar deviation at the wrist, and this requires
more muscle contractions to perform a task compared to in-
line handle or open techniques [13]. During laparoscopic
surgery the majority of the surgeon’s movements are at the
level of the hands, wrists and, to a lesser degree, the shoul-
ders. The rest of the body is in an upright position, which
may be responsible for the neck and back discomfort asso-
ciated with laparoscopy [14]. The current laparoscopic
instrumentation allows only four DOF. In contrast the
EndoWrist in the da Vinci system has seven DOF at the tip123
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NASA has a total of 14 DOF [15], and the human hand is of
course the most dexterous, with 36 DOF [16]. This limita-
tion of laparoscopy results in a restriction of the manoeu-
vrability of the surgeon and contributes to the ergonomic
awkwardness associated with complex laparoscopic proce-
dures, especially those involving suturing. Normal 3-D
vision is lost due to the monoscopic camera system, reduc-
ing the depth of Weld and causing eyestrain for the surgeon
[17]. The cumulative eVect of these problems is to increase
overall fatigue and stress and restrict the number of mini-
mally invasive surgical procedures that can be performed
by one surgeon in a given operative session [18]. The mas-
ter–slave robotic systems may help resolve some of the
ergonomic obstacles described above. With the da Vinci™
system, the surgeon is seated at a console remote from the
patient, providing a much more ergonomic posture than
that of the traditional patient-side surgeon. The Wngertip
controls allow “intuitive” rather than “fulcrum”-type con-
trol over the laparoscopic instruments, which may help to
reduce fatigue in the upper extremity and neck. The restora-
tion of increased DOF compared to the four DOF of con-
ventional laparoscopy may oVer beneWts for complex
laparoscopic tasks [19]. This may also decrease the exces-
sive wrist strain during laparoscopy. 3-D stereoscopic
vision can also provide advantages over the 2-D mono-
scopic vision of conventional laparoscopic systems [20].
We are currently comparing the impact of the physical
activities of both techniques on surgeons. Standard tasks
are performed using open, laparoscopic and robotically
assisted techniques. Electromyographic (EMG) sensors
record muscular activity; motion capture cameras capture
postural variation. An analysis of the data obtained will
allow objective comparison of these techniques and will
help us to understand their impact on surgeons [21].
Financial hurdles
There are currently 400 da Vinci systems the United States
compared to seven in the UK; this corresponds to one sys-
tem per 750,000 of the US population compared to one in
15 million in the UK. DiVerences in the structures of the
health systems in both countries partially account for this
discrepancy. In the UK at present only large training cen-
tres are able to purchase da Vinci systems, often with the
support of large charitable organisations [22]; however,
there is increasing interest from the private sector. The cur-
rent cost of the da Vinci system is £700,000 ($1.2 million).
This is not the only cost; annual maintenance is £70,000
($138,000). The instrument cost of a typical robotic-
assisted prostatectomy case at Guy’s Hospital, London is
around £1,000 ($1,700), with an additional £650 ($1,100)
for consumables, compared to £950 ($1,600) for laparo-
scopic radical prostatectomy and £670 for open radical pro-
statectomy [23]. Payment by results is a new system
implemented recently by the British government, and it is
changing the landscape in health care. This makes length of
stay (LOS) a key productivity and eYciency variable for
National Health Service (NHS) hospitals. A one-day stay in
hospital in the UK costs £214 ($360)—£225 ($380) for
general wards—and ranges between £1,300 ($2,200) and
£1,700 ($2,900) for intensive care beds [24]. This may
prove vital for robotic-assisted operations, as early dis-
charge from hospital is a possible advantage.
In their study, Link et al. [25] suggest that depreciation
and maintenance costs can be minimised if the number of
robotic cases is increased. In another study, Scales et al.
[26] indicated that while prolonged operative time
increases the cost exponentially, increasing the number of
robotic-assisted prostatectomies to ten per week can be
cost-equivalent to open prostatectomy.
Training of a team
Another essential task to overcome in addition to Wnancial
problems is to train a robotic-assisted surgical team. In our
unit, the members of our robotic group (including surgeons
and nurses) were initially trained in a da Vinci dry lab set-
ting and subsequently in a cadaveric lab in Paris. The team
travelled to the Vatikutti Institute in Detroit to observe live
cases. Later an experienced urologist from the Vatikutti
Institute locally mentored our team in our initial cases in
the UK [22]. Other teams had similar training [27].
The clinical experience
Several centres in the UK started robotic surgery pro-
grammes shortly after master–slave systems became avail-
able commercially. This trend Wrst started with cardiac
surgery. Deeba and Darzi [28] reported 102 cases of
robotic-assisted cardiac surgery. Undre and Darzi from the
same institution reported robotic-assisted Heller cardiomy-
otomy (n = 5) [29] and robotic-assisted adrenalectomy
(n = 2) [30]. Subsequently the technology was adopted
mainly by urologists. To date there are seven centres in the
UK that have started robotic-assisted surgery programmes.
The trend in the UK is the same as in the rest of the world,
robotic-assisted prostatectomy (RAP) is the most com-
monly performed procedure. In their Wrst 50 RAP cases,
Mayer et al. [31] reported an operative time of nearly
370 min, a transfusion rate of 12% with median blood loss
of 700 ml, a 36% complication rate including two rectal
injuries, a hospital stay of four days, and 22% positive mar-
gins. Results are mostly comparable to published early123
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showed decreased operative time, blood loss, and positive
margins [33, 34]. Many other urological procedures have
been performed. Murphy et al. [35] reported their experi-
ences in robotic renal surgery using da Vinci systems. They
have performed robotic-assisted pyeloplasty (n = 15), sim-
ple nephrectomy (n = 2), radical nephrectomy (n = 1),
nephrouretrectomy (n = 2) and live donor nephrectomy
(n = 4) [35]. The mean operative time was 215 min, blood
loss 75 ml, complication rate 2.7% and hospital stay
2.9 days. Three of the nephrectomies were performed retro-
peritoneally, and four using hand-assisted approach. Com-
plications included laparotomy for liver injury. Dasgupta
and Khan [22] from the same group reported robotic-
assisted colposuspension. Table 1 summarises the series of
robotic cases in the UK.
Robotic-assisted cystectomy
Cystectomy is the most eVective treatment for invasive
bladder cancer, uncontrollable superWcial cancer and
refractory carcinoma in situ; however, it can be a morbid
operation with high risk of complications and slow recov-
ery [36]. A minimally invasive approach was shown to
speed recovery [37], decrease blood loss and postoperative
pain [38] and has acceptable functional and oncological
outcome [39]. However laparoscopic cystectomy (LC) is
still a lengthy procedure and requires extensive skills which
limit this technique to a few centres [40]. Robotic-assisted
surgery has the potential to overcome some of the laparo-
scopic diYculties. Robotic-assisted cystectomy (RAC) was
Wrst described by Menon et al. [41] in 2003 using the da
Vinci system, the Vattikuti technique. Access is through six
ports utilizing a transperitoneal approach. An extracorpo-
real ileal conduit or orthotopic bladder is fashioned, with
the robot redocked for anastomosis in the case of neoblad-
der. A team from Sweden perform all of the procedure
intracorporeally [42]. Rhee et al. [43] dissect lymph nodes
through an open incision. RAC is still only performed by a
limited number of centres worldwide; however, it is gain-
ing wider acceptance. Early series results reXect the advan-
tages of laparoscopic surgery: less blood loss, early
recovery and adequate cancer control [43–45]. However
larger series and controlled trials are needed. There is still a
lack of long-term oncological follow-up. Recent series are
summarized in Table 5. Here the authors report their
series—the Wrst in the UK and one of the Wrst in Europe.
Our team consists of two surgeons experienced in open cys-
tectomy and one experienced in robotic-assisted surgery.
Our technique is a modiWcation of the Vattikuti technique.
The Guy’s operative technique
Patients have bowel preparation and overnight intravenous
Xuids. Patients above 60 are digitalised as recommended by
urologists experienced in open cystectomy, to prevent atrial
Wbrillation. They are placed in the extended lithotomy posi-
tion with a 45° Trendelenburg tilt. A disposable sigmoido-
scope is introduced per rectum in male patients and a
methylene-blue-soaked swab per vaginum in female
patients. After catheterisation, a six-port transperitoneal
approach is used. Each procedure involves three sur-
geons—one at the console and one on each side of the
patient.
Posterior dissection
The distal ends of ureters are sent for frozen section analy-
sis. An inverted U-shaped incision is made in the perito-
neum of the Pouch of Douglas. The posterior layer of
Denonvillier’s fascia is then incised in the midline and the
plane between the rectum and the prostate developed. In
females the ovarian vessels are controlled and divided. The
plane between the rectum and uterus is developed and the
uterine arteries controlled.
Lateral dissection
Dissection is continued medial to the external iliac veins to
carefully preserve the obturator nerves and expose the lat-
eral pelvic wall. This delineates the lateral pedicles to the
bladder (and uterus in females), which are controlled with
the ACE Harmonic™ scalpel (Ethicon Endosurgery, Liv-
ingston, UK).
Anterior dissection
The bladder is Wlled with 200 ml of formal saline to aid
identiWcation and dropped by an inverted U incision to
include the urachus. The endopelvic fascia is opened and
Table 1 Robotic-assisted cases in the UK
Authors Year Robotic-assisted cases N
Undre et al. [29] 2004 Heller cardiomyotomy 5
Undre et al. [30] 2004 Adrenalectomy 2
Rose et al. [46] 2006 Retroperitoneal 
nephrouretrectomy
2
Deeba et al. [47] 2006 Cardiac surgery 102
Mayer et al. [48] 2006 Prostatectomy 50
Mruphy et al. [35] 2007 Pyeloplasty 15
Nephrectomy 2
Radical nephrectomy 1
Live donor nephrectomy 4
Dasgupta et al. [49] 2007 Cystectomy 19123
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formed for potent male patients. The distal urethral margin
is sent for frozen section. In females the urethra is dissected
fully to the external meatus and the posterior vaginal fornix
opened. The previously placed methylene blue swab
becomes visible, indicating that the correct plane had been
entered. The lateral vaginal walls are transected. The cys-
tectomy specimens are secured in a bag for later retrieval.
Leakage of carbon dioxide from the vagina is reduced by a
waterproof dressing applied externally. The vagina is then
closed longitudinally by continuous intracorporeal suturing
with 2-0 vicryl.
Lymphadenectomy and transposition of left ureter
Using robotic bipolar forceps and scissors, careful bilateral
lymphadenectomy is performed. The limits of the dissec-
tion are the genitofemoral nerve laterally, the bifurcation of
the common iliac artery proximally and the node of Cloquet
distally. Care is taken to preserve the obturator nerve. The
lymph nodal packs are placed in separately marked laparo-
scopic sacks. An Endoloop™ (Ethicon Endosurgery, Liv-
ingston, UK) is applied on the distal end of the left ureter
which is then transposed under the sigmoid mesocolon to
the left by pulling the Endoloop™ through. The distal ends
of the ureters are held together with a laparoscopic grasper
introduced through the left-sided 5-mm assistant port.
Urinary diversion
All diversions are performed extracorporeally. For ileal con-
duits, a 15-cm segment of ileum about 15 cm proximal to the
ileocaecal junction is held in laparoscopic graspers intro-
duced through the most lateral right-sided 10-mm port. The
robot is undocked. The previously bagged bladder and
lymph nodal specimens are extracted through a 5–7 cm inci-
sion. In thin patients this should be an appendix muscle-
splitting incision made by extending a lateral port, while in
overweight patients (BMI > 30 Kg/m2) a subumbilical mid-
line incision is preferred for easier left ureteric access. The
graspers holding the ureters and ileal segment are brought to
the surface through this incision. The ileal loop is isolated on
its mesentery, bowel continuity restored with staplers and
the mesenteric window closed. Ureteroileal anastomosis is
performed over 8F feeding tubes using a Wallace I tech-
nique. The distal end of the conduit is fashioned as a stoma
at a previously marked site on the abdominal wall. A sump
drain is introduced into the conduit to prevent any anasto-
motic pressure and leak from subsequent stomal oedema.
Studer pouches are created through lower midline incisions
and anastomosed to the urethral stump by six robotically
placed 3-0 monocryl sutures. A 20 F drain is placed in the
pelvis. The port sites and wounds are closed with absorbable
sutures. A litre of icodextrin (Adept, ML Pharmaceuticals,
Warrington, UK) is instilled into the abdomen and drained
after an hour to reduce the risk of bowel adhesions.
Post-operative care
Initially all of our patients were electively managed in a
high-dependency unit, as this was a new procedure in our
centre. The nasogastric tube is removed next morning and
oral liquids started as tolerated. Early mobilisation and
chest physiotherapy are encouraged. Most patients are dis-
charged with their pelvic drains and ureteric catheters in
situ, which are removed at 2–3 weeks. Patients are seen
again at six weeks and have an abdominal ultrasound at
three months, CT scans at six months and then at six-
monthly intervals. At these visits they have clinical exami-
nation and assessment of serum haemoglobin, electrolytes,
creatinine, chloride and bicarbonate.
Cases and outcome
We have performed 19 cases. Patients diagnosed with T4
bladder cancer and those having previous pelvic radiother-
apy or abdominal surgery were excluded. All procedures
were completed without conversion; two patients had Stu-
der pouches fashioned. Bowel function returned on day 1
except in the pouches. Patient satisfaction was high: 30
(29–31) out of 32 on a validated patient satisfaction ques-
tionnaire (CSQ-8). Four patients had complications. One
patient had rectal injury in a T3 adenocarcinoma such that
the urethra needed colostomy; one of the Studer pouch
patients developed urethrovesical stricture and was treated
successfully with endoscopic dilatation. A patient had port
site bleeding which needed blood transfusion, and one
patient developed incisional hernia and was surgically
Table 2 Patient demographics of robotic-assisted radical cystectomy
at Guy’s Hospital
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240 J Robotic Surg (2008) 1:235–242repaired. There were no perioperative deaths. On follow-
up, two patients developed metastasis, one of which has
died. Patient demographics, operative details, and outcome
are all summarized in Tables 2 and 3, 4 and 5.
Patient experience
Little is known about the public perception of robotic sur-
gery in the United Kingdom. In the Wrst year of setting up
our robotic programme, we had eight patient enquiries from
across the UK. The referrals largely came from colleagues
in other centres. This was surprising, and reXected some
early reservations amongst patients. However, subsequent
widespread media coverage has increased patient aware-
ness of the possibilities oVered by robotic surgery, and has
led to a market-driven demand for robotic surgery for some
procedures. At Guys we receive public exposure via a day-
time hospital programme which is broadcast by the BBC.
“City Hospital” shows real-life medical procedures, some
broadcast live. As a result we often get queries about our
techniques and the availability of our services. In addition,
we have held a robotics “patient day”. On this occasion
patients and their partners were invited to attend presenta-
tions and discussions on the robotic programme and give
Table 3 Operative details of robotic-assisted radical cystectomy at
Guy’s Hospital
Min minutes, ml millilitre, d days, w weeks
Median values
Operative time (min) 320 (295–510)
Docking time (min) 6 (2–9)
Blood loss (ml) 150 (100–1,150)
Clear surgical margins 100%
Hospital stay (d) 10 (6–22)
Full recovery (w) 5 (4–12)
Lymph node dissection 16 (6–25)
Conversion None
Table 4 Functional and oncological outcome in robotic-assisted radi-
cal cystectomy at Guy’s Hospital
Complication (21%) One port site bleeding needing blood 
transfusion
One rectal injury in a case with urethral 
adenocarcinoma, colostomy
One incisional hernia, repaired
One urethrovesical stricture 
(Studer pouch), dilatation
Follow-up (30 months)
Overall survival 94% (18/19)





























































































































































































































































































































































































































































































































J Robotic Surg (2008) 1:235–242 241feedback on their experiences. We addressed two main
areas—their expectations of the service, and what level of
information should be available to patients undergoing
robotic surgery. Many important topics were discussed,
some regarding the good experiences patients had regard-
ing the video availability of the procedures, leaXets and
postoperative pain control. Another issue was the diYculty
involved in patients obtaining access to robotic surgery due
to the paucity of machines in the UK. Most patients pre-
ferred to receive counselling about the robot from a special-
ist nurse with a Wxed contact telephone number in case of
any diYculty.
Discussion
Robotic surgery presents many appealing advantages to
both surgeons and patients. It oVers all of the beneWts of
laparoscopic surgery; in addition it provides a steady
tremor-free scaled motion. The intuitive movements and
the enhanced DOF with the 3-D stereoscopic vision suggest
an advantage over laparoscopic surgery. The early func-
tional outcomes of robotic radical prostatectomy are prom-
ising; however, most of the comparative studies are from
single institutions, and lack a high level of evidence [32].
The high cost of purchasing and maintaining the instru-
ments of the robotic system is one of its many disadvan-
tages. The absence of haptic feedback remains an important
issue, but this technology may well be introduced in the
near future. The current da Vinci system is still sizeable and
requires a team of trained staV to set it up over a lengthy
time period. The availability of the robotic systems to only
a limited number of centres reduces surgical training oppor-
tunities, and this is particularly obvious in Britain. How-
ever, overall, robotic surgery in the UK is evolving, with
public acceptance and awareness increasing steadily.
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